Tepotinib price revealed: How much does a box cost? What about after medical insurance reimbursement?

In the field of anti-cancer drugs, Tepotinib (Tepotinib) has attracted much attention for its precise therapeutic effect on MET exon 14 skipping mutations. However, for many patients, the price of a drug is an important consideration. This article will give you a detailed introduction to the price and medical insurance reimbursement of tepotinib.

1. The price difference between original drugs and generic drugs

The original drug of Tepotinib is produced by Merck Healthcare KGaA in Germany. Its price is relatively high. The price of a box (usually 225mg*60 tablets) can reach more than 30,000 yuan. This is undoubtedly a considerable expense for many families. In order to reduce the financial burden on patients, multiple versions of generic drugs have appeared on the market, such as the Lucius version and the ASEAN version. The Lucius version of the generic drug costs about more than 7,000 yuan, while the ASEAN version is slightly higher, close to 9,000 yuan per box. The price of generic drugs is relatively affordable and can save patients a lot of costs.

2. Medical insurance reimbursement situation

Unfortunately, tepotinib has not yet been included in the national medical insurance directory. This means that domestic patients need to pay for the full amount of original drugs at their own expense and cannot enjoy reimbursement from medical insurance. For patients requiring long-term treatment, this undoubtedly increases their financial pressure.

In short, tepotinib, as a precise targeted anti-cancer drug, provides a new treatment option for patients with non-small cell lung cancer carryingMET exon 14 skipping mutations. However, its high price and lack of coverage in medical insurance also bother some patients. It is expected that as the medical insurance policy continues to improve in the future, the price of tepotinib can be gradually reduced and included in the medical insurance catalog. When choosing drugs, patients should fully consider their own financial situation and treatment needs, fully communicate with their doctors, and formulate appropriate treatment plans.